Matches in Nanopublications for { ?s ?p "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP878333.RAgcKXjPI8VQLvwVCeNEwx3u0NYQtYuPrsxzhQVFEAq2g130_assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP878333.RAgcKXjPI8VQLvwVCeNEwx3u0NYQtYuPrsxzhQVFEAq2g130_provenance.
- NP890327.RAtEFiwQ8VSVysl9jgrddXKnmwI2Kx1JW5W9wLf3L8apQ130_assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP890327.RAtEFiwQ8VSVysl9jgrddXKnmwI2Kx1JW5W9wLf3L8apQ130_provenance.
- assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291861.RAD92-iAt1PiMmiwPRXPg19qzL8PExj1xe0q0j9hNhIns130_provenance.
- NP427441.RAXsywIztFEBZCoYeIEIlNQ3SVCbUzwe4pqpmC6B4XPJc130_assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427441.RAXsywIztFEBZCoYeIEIlNQ3SVCbUzwe4pqpmC6B4XPJc130_provenance.
- NP291902.RAHNL_T-WUMrD_WDiz0n1L2gDBRY3_mvr0Xfl2GszaA6g130_assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291902.RAHNL_T-WUMrD_WDiz0n1L2gDBRY3_mvr0Xfl2GszaA6g130_provenance.
- NP427446.RA9DfEpfKHOZ1Eh8u6UsbofgvNRI1HpEox7ZxIs6M9z5o130_assertion description "[Conversely, the lack of the dominant costimulatory molecules, CD80 (B7.1) and CD86 (B7.2) could be a possible explanation of poor immunogenicity of OVCA tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427446.RA9DfEpfKHOZ1Eh8u6UsbofgvNRI1HpEox7ZxIs6M9z5o130_provenance.